{
  "id": 4726784,
  "title": "Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns",
  "url": "https://urgent.news/2026/08/31/novartis-bristol-myers-pause-autoimmune-car-t-trials-due-to-safety",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-31T21:38:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/novartis-bristol-myers-autoimmune-cell-therapy-trial-halt/829218/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Side effects observed in testing have led Novartis to halt development of rap-cel in multiple indications and Bristol Myers to voluntarily pause its zola-cel program.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused",
        "url": "https://urgent.news/2026/09/01/three-deaths-in-car-t-trials-prompt-halt-by-novartis-bristol-myers",
        "published": "2026-09-01T00:01:19.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}